Navigation Links
Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
Date:5/21/2013

TEANECK, N.J., May 21, 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated for Sept 17-19 in NJ has attracted the greatest number of "Emerging" small molecule biotech company chemists ever, reports its President, Mark Alexay .  "No one saw this coming", commented Alexay.  "But suddenly everyone plans to attend this year.  The show's still 4 months away and we may end up attracting hundreds of different companies.  This is a big surprise and great news for attendees". Thecurrent list of 80 attending pharmaceutical, emerging, virtual, and other small molecule biotech companies is at http://chemoutsourcing.com/popup.php

Alexay elaborated, "The Emerging companies need timely information about how to get their molecules scaled up quickly and properly.  They also need to meet their suppliers in one place.  This is why they attend.  It's makes efficient use of their time without trips to Europe or Asia."    

"They have also remarked that it's helpful to benchmark best practices and meet their peers from other small molecule biotech companies.  There's no other show in the world that brings together so many chemists from "Emerging" and "Virtual" companies.  If small and lean is the new pharmaceutical industry drug development model then the show is well-positioned to serve it."

Pharma ChemOutsourcing is now in its 7th year and takes place every September at the Jersey Shore.  The show annually attracts 700-800 Pharmaceutical company chemists and suppliers of chemical services to the industry. The show emphasizes Outsourcing of Discovery and Medicinal Chemistry, Process Research, and  Chemical Development of Intermediates, API's, a
'/>"/>

SOURCE Apaporis, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
2. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
3. NextDocs Launches QuickStart for Emerging Growth Companies
4. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
5. For Treatment of Extensive-Disease Small-Cell Lung Cancer (ED-SCLC), No Emerging Therapy is Likely to Replace Etoposide/Carboplatin as the Standard of Care Before 2022
6. Details of New Synthetic Vaccine for Emerging H7N9 Threat Revealed at BIO International Convention in Chicago, April 22-25
7. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
8. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
9. Emerging Precision Medicine Powerhouse Changes Name to Increase Visibility and Overall Awesomeness
10. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
11. Innophos CFO To Present At 2013 Sidoti Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  The report on breast cancer therapeutics: pipeline ... drugs on the basis of the molecules which are ... inner lining of milk ducts or lobules responsible for ... tumor that can spread to other cells present in ... lobules is referred as lobular carcinoma, while the other ...
(Date:9/2/2015)... The quantum dot market report analyzes the ecosystem of the ... product includes medical devices, display, and others. The others segment ... storage, QD laser, and transistor. The application segment covers the ... The report also provides the geographic view for major regions ... Europe , Asia-Pacific (APAC), and ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... dystrophy is an X-linked disease, which generally affects ... muscle degeneration and weakness. The disease is caused ... result in the lack of production of dystrophin ... in individuals. The lack of dystrophin weakens muscle ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... (Nasdaq: ALTH ) today announced the initiation ... multi-center dose,escalation study of the Company,s targeted chemotherapeutic ... non-Hodgkin,s lymphoma (NHL). "We are pleased to ... Cagnoni, M.D., Chief Medical Officer of Allos. "RH1 ...
... Appropriate Patient Selection Criteria for Future Field ... ... Corporation (Nasdaq: DVAX ) presented yesterday a detailed,analysis of data ... for ragweed allergic rhinitis. The,data were reported yesterday at the annual ...
Cached Medicine Technology:Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 2Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 3
(Date:9/2/2015)... ... , ... The CRISPR-Cas9 system introduces double-strand DNA breaks at a ... either a chimeric single guide RNA (sgRNA) or two short RNAs (a CRISPR RNA ... or crRNA) to create a break in the target DNA that causes functional protein ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading ... two leaders who will deliver keynote presentations at the upcoming Digital Healthcare Innovation ... Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the morning ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 02, 2015 , ... ... company, American Well Corp., contracted to handle the telehealth services of more than 12 ... Blue Cross and Blue Shield Plans takes a look this growing trend, interviewing executives ...
(Date:9/2/2015)... ... ... Date and time: Oct. 3, 2015, 9 a.m. to 4 p.m. ... Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The Quakertown, Pa.-based ... Sam Keen based on his new book which he co-authored with his son, Gifford ...
(Date:9/2/2015)... ... 2015 , ... RxNT , an innovative software solutions ... cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks the ... in health technology, RxNT was one of the first to build an ePrescribing ...
Breaking Medicine News(10 mins):Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2
... decision making on issues whose consequences will only be ... annual Addiction Science Awards at this year,s Intel International ... science competition for high school students. The Intel ISEF ... Thursday night in Los Angeles. The awards were presented ...
... best efforts of scientists, in many cases the underlying causes of ... team of Australian and Swedish researchers, however, will go a long ... published in Science this week, a small set of ... are crucial to unravelling the secrets of male infertility. ...
... , THURSDAY, May 12 (HealthDay News) -- Representatives ... that she entered a facility for surgery to remove ... that can occur on the meninges, the brain,s protective ... who has been monitoring this for years, and a ...
... HealthDay Reporter , FRIDAY, May 13 (HealthDay News) -- Every ... to hungry students in the fourth-largest school district in the ... food and menu management for the Miami-Dade County Public Schools, ... that goal. The move by the U.S. Department of ...
... levels of cardiac troponin T (cTnT) or I (cTnI) ... of all-cause mortality and long-term adverse events such as ... nonemergent percutaneous coronary intervention (PCI) could improve long-term outcomes ... online in Catheterization and Cardiovascular Interventions , a ...
... This press release is available in French . ... it,s definitely going on., A recent survey, led by McGill ... reports that one in five respondents physicians and psychiatrists ... placebo. Moreover, an even higher proportion of psychiatrists (more than ...
Cached Medicine News:Health News:Altruistic decision making focus of NIDA's Addiction Science Award 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 3Health News:Research breakthrough on male infertility 2Health News:Brain Surgery for Mary Tyler Moore to Remove Benign Tumor 2Health News:School Systems Struggle With Lunchroom Costs 2Health News:Elevated protein levels in cardiac muscles could predict mortality following angioplasty 2Health News:The power of placebos 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm round tip. Blade dimension: 16.5 mm x 5.2 mm x 3.8 mm x 2.4 mm....
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: